Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Northeast Development & Management (NDM) is a clinical research site management organization (SMO) that specializes in the execution of Phase II through IV clinical trials for the pharmaceutical and biotechnology industries. Based in Yardley, Pennsylvania, the company operates a dedicated research facility with a primary therapeutic focus on dermatology, podiatry, and internal medicine. NDM provides comprehensive site services including patient recruitment, study coordination, and regulatory management, leveraging a large database of potential participants. The organization is closely affiliated with Yardley Dermatology Associates, allowing for seamless integration between clinical care and advanced research. By maintaining high standards of data integrity and GCP compliance, NDM serves as a key partner for sponsors seeking to evaluate new therapeutic agents in a real-world clinical setting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Northeast Development & Management.